Steris (STE) Cash from Financing Activities (2018 - 2026)
Steris (STE) posted quarterly Cash from Financing Activities of -$97.9 million for Q1 2026, up 45.03% year-over-year from -$67.5 million in Q1 2025, and little changed quarter-over-quarter from -$98.0 million in Q4 2025.
Steris (STE) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Steris' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$97.9 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 45.03% year-over-year to -$97.9 million; the TTM figure through Mar 2026 stood at -$568.2 million (up 63.86% YoY), while the FY2026 annual figure was -$568.2 million, up 63.86% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$97.9 million, roughly flat from -$98.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $470.2 million in Q3 2023, with the low at -$998.9 million in Q2 2024.
- The 5-year median for Cash from Financing Activities is -$178.1 million (2025), against an average of -$176.4 million.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 1146.13% in 2023, then tumbled 367.57% in 2024.
- Steris' Cash from Financing Activities stood at -$120.4 million in 2022, then tumbled by 64.43% to -$198.0 million in 2023, then dropped by 8.29% to -$214.4 million in 2024, then jumped by 54.29% to -$98.0 million in 2025, then increased by 0.1% to -$97.9 million in 2026.
- Business Quant data shows STE's Cash from Financing Activities at -$97.9 million in Q1 2026, -$98.0 million in Q4 2025, and -$159.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | -271.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -213.50 Mn |
| Jun 30, 2026 | -213.50 Mn |
| Mar 31, 2026 | -97.90 Mn |
| Mar 31, 2026 | -97.90 Mn |
| Dec 31, 2025 | -98.00 Mn |
| Dec 31, 2025 | -98.00 Mn |
| Sep 30, 2025 | -159.20 Mn |
| Sep 30, 2025 | -159.20 Mn |
| Jun 30, 2025 | -213.10 Mn |
| Jun 30, 2025 | -213.10 Mn |
| Mar 31, 2025 | -178.10 Mn |
| Mar 31, 2025 | -178.10 Mn |
| Dec 31, 2024 | -214.40 Mn |
| Dec 31, 2024 | -214.40 Mn |
| Sep 30, 2024 | -181.00 Mn |
| Sep 30, 2024 | -181.00 Mn |
| Jun 30, 2024 | -998.90 Mn |
| Jun 30, 2024 | -998.90 Mn |
| Mar 31, 2024 | -143.78 Mn |
| Mar 31, 2024 | -143.78 Mn |